Literature DB >> 16542159

A systematic review of depression and mental illness preceding Parkinson's disease.

L Ishihara1, C Brayne.   

Abstract

Depression has been reported in several studies to be more common in Parkinson's disease (PD) patients than in the general population, and there may be overlap in the pathophysiology of the two conditions. Anxiety and other mental disorders have also been examined for possible association with PD because of their effects on the brain. MEDLINE, EMBASE and PSYCHINFO databases were searched systematically for existing systematic reviews or meta-analyses and primary research articles. Past studies and reviews have focused on co-morbidity of depression or mental disorders and PD, but as yet there have been no systematic reviews of the evidence that these conditions precede PD. Articles without robust methodology were excluded by specified criteria, based on published quality scoring criteria. Three cohort studies, one nested case-control study, and 10 case-control studies are included in the current systematic review. Premorbid depression was significantly more common in PD patients than in those without a diagnosis of PD in five of six case-control studies and three cohort studies. Premorbid anxiety may also be associated with PD although the evidence was not as strong. A few studies have looked at dementia as a co-morbid or sequel, but never as a predictor of PD.

Entities:  

Mesh:

Year:  2006        PMID: 16542159     DOI: 10.1111/j.1600-0404.2006.00579.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  78 in total

Review 1.  Functional and behavioral consequences of Parkinson's disease-associated LRRK2-G2019S mutation.

Authors:  Deanna L Benson; Bridget A Matikainen-Ankney; Ayan Hussein; George W Huntley
Journal:  Biochem Soc Trans       Date:  2018-12-04       Impact factor: 5.407

2.  Parkinson disease: Depression-risk factor or early symptom in Parkinson disease?

Authors:  Albert F Leentjens
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

3.  Cognition in individuals at risk for Parkinson's: Parkinson associated risk syndrome (PARS) study findings.

Authors:  Lama M Chahine; Daniel Weintraub; Keith A Hawkins; Andrew Siderowf; Shirley Eberly; David Oakes; John Seibyl; Matthew B Stern; Kenneth Marek; Danna Jennings
Journal:  Mov Disord       Date:  2015-08-21       Impact factor: 10.338

Review 4.  The Therapeutic Potential of Exercise to Improve Mood, Cognition, and Sleep in Parkinson's Disease.

Authors:  Gretchen O Reynolds; Michael W Otto; Terry D Ellis; Alice Cronin-Golomb
Journal:  Mov Disord       Date:  2015-12-30       Impact factor: 10.338

5.  The association between motor subtypes and alexithymia in de novo Parkinson's disease.

Authors:  Michele Poletti; Daniela Frosini; Cristina Pagni; Claudio Lucetti; Paolo Del Dotto; Gloria Tognoni; Roberto Ceravolo; Ubaldo Bonuccelli
Journal:  J Neurol       Date:  2010-12-25       Impact factor: 4.849

6.  A novel PDE9 inhibitor WYQ-C36D ameliorates corticosterone-induced neurotoxicity and depression-like behaviors by cGMP-CREB-related signaling.

Authors:  Xian-Feng Huang; Wen-Tao Jiang; Li Liu; Fang-Chen Song; Xia Zhu; Gui-Lan Shi; Shu-Ming Ding; Heng-Ming Ke; Wei Wang; James M O'Donnell; Han-Ting Zhang; Hai-Bin Luo; Yi-Qian Wan; Guo-Qiang Song; Ying Xu
Journal:  CNS Neurosci Ther       Date:  2018-05-02       Impact factor: 5.243

Review 7.  [Depression and neurological diseases].

Authors:  D Piber; K Hinkelmann; S M Gold; C Heesen; C Spitzer; M Endres; C Otte
Journal:  Nervenarzt       Date:  2012-11       Impact factor: 1.214

8.  Reduced striatal tyrosine hydroxylase in incidental Lewy body disease.

Authors:  Thomas Gerald Beach; Charles H Adler; Lucia I Sue; Jeffrey B Peirce; Jyothi Bachalakuri; Jessica E Dalsing-Hernandez; Lih Fen Lue; John N Caviness; Donald J Connor; Marwan N Sabbagh; Douglas G Walker
Journal:  Acta Neuropathol       Date:  2007-11-06       Impact factor: 17.088

9.  Evaluation and management of the non-motor features of Parkinson's disease.

Authors:  Steven Wishart; Graeme J A Macphee
Journal:  Ther Adv Chronic Dis       Date:  2011-03       Impact factor: 5.091

10.  Use of antidepressants and the risk of Parkinson's disease: a prospective study.

Authors:  A Alonso; L A García Rodríguez; G Logroscino; M A Hernán
Journal:  J Neurol Neurosurg Psychiatry       Date:  2009-06       Impact factor: 10.154

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.